Tuesday - March 17, 2026

Category Archives: Science

Codex Labs to Showcase Skin-Gut Biome Innovations at Three Major Dermatology Conferences

DENVER, Colo. – March 11, 2026 – Codex Labs, a biotech skincare company focused on integrative dermatology and microbiome-friendly skin-gut solutions, is excited to announce its participation in the Dermatology Nurses’ Association (DNA) 44th annual convention, the Society of Pediatric … Continue reading →

Dr. Tommy Rhee’s Research Accepted for Presentation at the 2026 ASIPP Annual Meeting

Dr. Tommy Rhee’s Research on Cell-Free Regenerative Signaling Accepted for Presentation at 2026 ASIPP Annual Meeting Tampa, FL – Dr. Tommy Rhee, regenerative medicine researcher and founder of RheeGen®, a patent-pending topical regenerative platform, announced that his latest research abstract has … Continue reading →

AI Platforms for Rapid Fashion Design and E‑commerce Video: Emerging Tools Empower Independent Designers and Small Teams

Independent fashion designers and small creative teams are embracing a new era where AI platforms are transforming how apparel is designed, visualized, and marketed online. Leading solutions like Style3D AI, ZMO AI, Runway, Pika Labs, Browzwear, TUKAcad, and Adobe Firefly … Continue reading →

Advanced Ovarian Cancer Treatment Pipeline Shows Strong Momentum as 50+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Advanced Ovarian Cancer Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Advanced Ovarian Cancer pipeline landscape. It covers the Advanced Ovarian Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Advanced Melanoma Clinical Trial Pipeline Expands as 55+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Advanced Melanoma Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the Advanced Melanoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Advanced Liver Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight

DelveInsight’s “Advanced Liver Cancer Pipeline Insights 2026” Report provides comprehensive insights about 50+ companies and 52+ pipeline drugs in the advanced liver cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Advanced Hepatocellular Carcinoma Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight “Advanced Hepatocellular Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Advanced Hepatocellular Carcinoma pipeline landscape. It covers the Advanced Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Advanced Gastric Carcinoma Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Advanced Gastric Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Advanced Gastric Carcinoma pipeline landscape. It covers the Advanced Gastric Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Future Of Gaming: AI automation and cross-platform hardware solutions lead February 2026 granted gaming patents

AI AUTOMATION AND CROSS-PLATFORM HARDWARE SOLUTIONS LEAD FEBRUARY 2026 GRANTED GAMING PATENTS PRAGUE – March 10, 2026 – Future of Gaming (FutureOfGaming.com) Publications today released its February 2026 Granted Patents Report, revealing a significant industry focus on solving consumer hardware frustrations … Continue reading →